GOLDMAN SACHS GROUP INC - AYTU BIOPHARMA INC ownership

AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 48 filers reported holding AYTU BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AYTU BIOPHARMA INC
ValueSharesWeighting
Q1 2022$54,000
-1.8%
50,146
+22.7%
0.00%
Q4 2021$55,000
-60.7%
40,867
-15.9%
0.00%
Q3 2021$140,000
+97.2%
48,593
+244.2%
0.00%
Q2 2021$71,000
-88.0%
14,118
-81.9%
0.00%
Q1 2021$592,00077,9580.00%
Other shareholders
AYTU BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 2,379,936$2,570,0000.05%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 10,880$12,0000.00%
Renaissance Technologies 765,469$827,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 53,530$58,0000.00%
Focused Wealth Management, Inc 209$00.00%
FEDERATED HERMES, INC. 5,633$6,0000.00%
JANICZEK WEALTH MANAGEMENT, LLC 1$00.00%
UBS Group AG 1$00.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 100$00.00%
IFP Advisors, Inc 2,400$16,0000.00%
View complete list of AYTU BIOPHARMA INC shareholders